Sandberg, A. L., R. Snyderman, M. M. Frank, and A. G. Osler. “Production of chemotactic activity by guinea pig immunoglobulins following activation of the C3 complement shunt pathway..” J Immunol 108, no. 5 (May 1972): 1227–31.
Frank, M. M., J. S. Sergent, M. A. Kane, and D. W. Alling. “Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study..” N Engl J Med 286, no. 15 (April 13, 1972): 808–12. https://doi.org/10.1056/NEJM197204132861503.
Schreiber, A. D., and M. M. Frank. “Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites..” J Clin Invest 51, no. 3 (March 1972): 575–82. https://doi.org/10.1172/JCI106846.
Schreiber, A. D., and M. M. Frank. “Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum..” J Clin Invest 51, no. 3 (March 1972): 583–89. https://doi.org/10.1172/JCI106847.
Buckley, R. H., R. I. Schiff, and D. B. Amos. “Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement.” J Immunol 108, no. 1 (January 1972): 34–44.
Buckley, R. H., D. B. Amos, W. B. Kremer, and D. L. Stickel. “Incompatible bone-marrow transplantation in lymphopenic immunologic deficiency. Circumvention of fatal graft-versus-host disease by immunologic enhancement.” N Engl J Med 285, no. 19 (November 4, 1971): 1035–42. https://doi.org/10.1056/NEJM197111042851901.